Literature DB >> 15491717

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue.

Leonard S Marks1, Munekado Kojima, Angelo Demarzo, David Heber, David G Bostwick, Junqi Qian, Frederick J Dorey, Robert W Veltri, James L Mohler, Alan W Partin.   

Abstract

OBJECTIVES: To investigate the relationship between diet and prostate cancer (CaP) among native Japanese (NJ) and second-generation or third-generation Japanese-American (J-A) men--focusing on the effects of animal fat and soy on prostatic tissues.
METHODS: The subjects were 50 Japanese men undergoing radical prostatectomy, 25 NJ living in Nagoya, Japan and 25 U.S.-born J-A men, living in Los Angeles, California. A priori, the NJ men were believed to be a low-fat, high-soy group and the J-A men, a high-fat, low-soy group. The studies included postoperative measurements of diet (Block questionnaire), body fat (bioimpedance), blood, urine, and prostatic biomarkers in malignant and adjacent normal tissue, using a tissue microarray made from the original paraffin blocks.
RESULTS: The NJ and J-A men were similar in age (65 to 70 years old; P <0.05), prostate-specific antigen level (7.1 to 8.6 ng/mL), prostate volume (35 to 38 cm3), and Gleason score (5.6 to 6.6), but their body composition differed. J-A men had more body fat (24% versus 19%), higher serum triglyceride levels (245 versus 106 mg/dL), lower estradiol levels (27 versus 31 ng/mL), and much lower urinary soy-metabolite levels (1:3) than NJ men (P <0.02). In both NJ and J-A groups, expression of numerous tissue biomarkers separated normal from CaP tissue, including markers for apoptosis (Bcl-2, caspase-3), growth factor receptors (epidermal growth factor receptor), racemase, 5-lipoxygenase, kinase inhibition (p27), and cell proliferation (Ki-67; all P <0.02). Furthermore, within both normal and CaP tissues, caspase-3 and 5-lipoxygenase were expressed more in NJ than in J-A men (P <0.01). Nuclear morphometry showed that the chromatin in each of the four groups (normal versus CaP, NJ versus J-A) was different (area under the curve 85% to 94%, P <0.01), despite fundamental genetic homogeneity.
CONCLUSIONS: NJ and J-A men, products of similar genetics but differing environments, were shown to have differences in body composition that could influence CaP evolution. The CaP specimens from the NJ and J-A men were histologically similar, but tissue biomarker expression, especially of lipoxygenase and the caspase family, suggested differing mechanisms of carcinogenesis. Differences in nuclear morphometry suggested the additional possibility of gene-nutrient interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491717     DOI: 10.1016/j.urology.2004.05.047

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  15 in total

1.  Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.

Authors:  Tze-Chen Hsieh; Joseph M Wu
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

2.  Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

Authors:  Mihai D Niculescu; Elena A Pop; Leslie M Fischer; Steven H Zeisel
Journal:  J Nutr Biochem       Date:  2006-09-08       Impact factor: 6.048

Review 3.  Prostate cancer: an emerging threat to the health of aging men in Asia.

Authors:  Ling Zhang; Bao-Xue Yang; Hai-Tao Zhang; Jin-Guo Wang; Hong-Liang Wang; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2011-05-09       Impact factor: 3.285

4.  Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.

Authors:  In-Chang Cho; Han Soo Chung; Kang Su Cho; Jeong Eun Kim; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Weon Seo Park; Eun Kyung Hong; Kang Hyun Lee
Journal:  Cancer Res Treat       Date:  2010-09-30       Impact factor: 4.679

5.  Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population.

Authors:  Lipsy Gupta; Hitender Thakur; Ranbir C Sobti; Amlesh Seth; Sharwan K Singh
Journal:  Mol Cell Biochem       Date:  2009-11-11       Impact factor: 3.396

6.  Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.

Authors:  Christopher D Gardner; Beibei Oelrich; Jenny P Liu; David Feldman; Adrian A Franke; James D Brooks
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

Review 7.  Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective.

Authors:  Naranamangalam R Jagannathan; Virendra Kumar; Rajeev Kumar; Sanjay Thulkar
Journal:  MAGMA       Date:  2008-07-17       Impact factor: 2.310

Review 8.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

9.  Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration.

Authors:  Antonino Battaglia; Gaëtan Devos; Guy Boeckx; Lieven Goeman; Lorenzo Tosco; Gert de Meerleer; Steven Joniau
Journal:  Curr Urol       Date:  2020-10-13

10.  Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men.

Authors:  Miao Liu; Takayuki Kurosaki; Motofumi Suzuki; Yutaka Enomoto; Hiroaki Nishimatsu; Tomio Arai; Motoji Sawabe; Takayuki Hosoi; Yukio Homma; Tadaichi Kitamura
Journal:  BMC Genet       Date:  2009-07-14       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.